NASDAQ:BBI
Delisted

Brickell Biotech Stock News

etoro logo Buy BBI
*Your capital is at risk
$1.94
+0 (+0%)
At Close: Feb 07, 2023
Delistings are commonplace in this bear market, however investors in Brickell Biotech and BBI stock are cheering some news today. The post Brickell Biotech (BBI) Stock Gains 50% Ahead of Meeting to Pr

3 Penny Stocks To Watch After GDP Report

02:03pm, Wednesday, 29'th Jun 2022 PennyStocks
Penny stocks to buy or avoid right now? You decide after seeing the latest updates from 3 companies. The post 3 Penny Stocks To Watch After GDP Report appeared first on Penny Stocks to Buy, Picks, New

3 Penny Stocks To Watch After GDP Report

10:03am, Wednesday, 29'th Jun 2022
Penny stocks to buy or avoid right now? You decide after seeing the latest updates from 3 companies.

Top Penny Stocks To Buy? 4 Biotech Stocks To Watch Now

11:20pm, Thursday, 09'th Jun 2022 PennyStocks
Biotech penny stocks to watch in June. The post Top Penny Stocks To Buy? 4 Biotech Stocks To Watch Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Biotech penny stocks to watch in June. The post Top Penny Stocks To Buy?
Upgrades B of A Securities upgraded the previous rating for Ritchie Bros Auctioneers Inc (NYSE:RBA) from Underperform to Neutral. In the first quarter, Ritchie Bros Auctioneers showed an EPS of $0.46,

Brickell (BBI) Reports Q1 Loss, Lags Revenue Estimates

09:35pm, Thursday, 12'th May 2022 Zacks Investment Research
Brickell (BBI) delivered earnings and revenue surprises of -33.33% and 52.33%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Brickell (BBI) delivered earnings and revenue surprises of -33.33% and 52.33%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Brickell Biotech, Inc. (NASDAQ:BBI ) Q1 2022 Earnings Conference Call May 12, 2022 4:30 PM ET Company Participants Garth Russell - IR, LifeSci Advisors Robert Brown - Chief Executive Officer Andrew Sk
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus BridgeBio Inks Licensing Pact With Bristol Myers For SHP2 Inhibitor In Oncology BridgeBio Pharma Inc 

Lyra Therapeutics, Inc. (LYRA) Reports Q1 Loss, Tops Revenue Estimates

12:35pm, Tuesday, 10'th May 2022 Zacks Investment Research
Lyra Therapeutics, Inc. (LYRA) delivered earnings and revenue surprises of 41.30% and 114.68%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stoc

Assertio (ASRT) Surpasses Q1 Earnings and Revenue Estimates

09:15pm, Monday, 09'th May 2022 Zacks Investment Research
Assertio (ASRT) delivered earnings and revenue surprises of 122.22% and 10.50%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

3 Strategies You Need to Know For Buying Penny Stocks

03:30pm, Saturday, 07'th May 2022 PennyStocks
Can these penny stocks trading strategies make you money in 2022? The post 3 Strategies You Need to Know For Buying Penny Stocks appeared first on Penny Stocks to Buy, Picks, News and Information | Pe
Can these penny stocks trading strategies make you money in 2022? The post 3 Strategies You Need to Know For Buying Penny Stocks appeared first on Penny Stocks to Buy, Picks, News and Information | Pe
BOULDER, Colo., May 05, 2022 (GLOBE NEWSWIRE) -- Brickell Biotech, Inc. (“Brickell” or the “Company”) (Nasdaq: BBI), a clinical-stage pharmaceutical company striving to transform patient lives
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE